Full metadata record
DC FieldValueLanguage
dc.creatorDucreux, M. (M.)-
dc.creatorAbou-Alfa, G.K. (Ghassan K.)-
dc.creatorBekaii-Saab, T. (T.)-
dc.creatorBerlin, J. (J.)-
dc.creatorCervantes, A. (Andrés)-
dc.creatorBaere, T. (T.) de-
dc.creatorEng, C. (C.)-
dc.creatorGalle, P. (P.)-
dc.creatorGill, S. (S.)-
dc.creatorGruenberger, T. (T.)-
dc.creatorHaustermans, K. (K.)-
dc.creatorLamarca, A. (Angela)-
dc.creatorLaurent-Puig, P. (P.)-
dc.creatorLlovet, J.M. (J. M.)-
dc.creatorLordick, F. (F.)-
dc.creatorMacarulla, T. (T.)-
dc.creatorMukherji, D. (D.)-
dc.creatorMuro, K. (K.)-
dc.creatorObermannova, R. (R.)-
dc.creatorO'Connor, J.M. (J. M.)-
dc.creatorO'Reilly, E.M. (E. M.)-
dc.creatorOsterlund, P. (P.)-
dc.creatorPhilip, P. (P.)-
dc.creatorPrager, G. (G.)-
dc.creatorRuiz-Garcia, E. (E.)-
dc.creatorSangro, B. (Bruno)-
dc.creatorSeufferlein, T. (T.)-
dc.creatorTabernero, J. (J.)-
dc.creatorVerslype, C. (Chris)-
dc.creatorWasan, H. (H.)-
dc.creatorVan-Cutsem, E. (E.)-
dc.date.accessioned2023-11-07T13:12:28Z-
dc.date.available2023-11-07T13:12:28Z-
dc.date.issued2023-
dc.identifier.citationDucreux, M.; Abou-Alfa, G. K.; Bekaii-Saab, T.; et al. "The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022". Esmo Open. 8 (3), 2023, 101567es
dc.identifier.issn2059-7029-
dc.identifier.urihttps://hdl.handle.net/10171/67827-
dc.description.abstractThis article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.-
dc.language.isoen-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.subjectÁrea de Medicina Clínica y Epidemiología-
dc.subjectHepatocellular carcinoma-
dc.subjectLiver transplantation-
dc.subjectChemoembolisation-
dc.subjectImmunotherapy-
dc.subjectRadioembolisation-
dc.titleThe management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022-
dc.typeinfo:eu-repo/semantics/review-
dc.description.noteThis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).-
dc.identifier.doi10.1016/j.esmoop.2023.101567-
dadun.citation.number3-
dadun.citation.publicationNameESMO OPEN-
dadun.citation.startingPage101567-
dadun.citation.volume8-
dc.identifier.pmid37263081-

Files in This Item:
Thumbnail
File
pdf.pdf
Description
Size
442.23 kB
Format
Adobe PDF


Statistics and impact

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.